GPR120 is a promising anti-obesity and anti-diabetes target as it mediates FFA signaling in the periphery to regulate insulin and glucagon-like peptide 1 [9]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.